Orion Oyj
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS
18 February 2025 at 16.00 EET
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly and indirectly by BlackRock, Inc. and its funds increased on 17 February 2025 above (5) per cent of Orion Corporation’s total shares.
Total positions of BlackRock, Inc. and its funds subject to notification:
| % of shares and voting rights (total of point A) | % of shares and voting rights through financial instruments (total of point B) | Total of both in % (points A + B) | Total number of shares and voting rights of issuer | |
| Resulting situation on the date on which threshold was crossed or reached | 5.02% shares Below 5% voting rights | 0.04% shares Below 5% voting rights | 5.07% shares Below 5% voting rights | 141,134,278 shares 763,427,275 voting rights |
| Position of previous notification (if applicable) | 4.99% shares Below 5% voting rights | 0.03% shares Below 5% voting rights | 5.02% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed:
Point A: Shares and voting rights:
| Class/type of shares ISIN code | Number of shares and voting rights | % of shares and voting rights | ||
| Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |
| FI0009014377 | 7,095,389 shares Below 5% voting rights | 5.02% shares Below 5% voting rights | ||
| POINT A SUBTOTAL | 7,095,389 shares Below 5% voting rights | 5.02% shares Below 5% voting rights | ||
Point B: Financial instruments according to SMA 9:6a:
| Type of financial instrument | Expiration date | Exercise / Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
| Securities Lent | N/A | N/A | Physical | 65,240 shares Below 5% voting rights | 0.04% shares Below 5% voting rights |
| POINT B SUBTOTAL | 65,240 shares Below 5% voting rights | 0.04% shares Below 5% voting rights |
Orion Corporation
| Liisa Hurme President and CEO | Olli Huotari EVP, Corporate Functions |
Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orionpharma.com
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S12.5.2025 08:01:21 CEST | Press release
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE
Aspo Plc12.5.2025 08:00:00 CEST | Press release
Aspo Plc’s Interim Report, January 1 – March 31, 2025: Strong start for year 2025 with continued profitability improvement
KBC Groep12.5.2025 08:00:00 CEST | Press release
KBC Group: Regulated information – 12 May 2025 before trading hours (08h00)
Norsk Hydro12.5.2025 08:00:00 CEST | Press release
Norsk Hydro: Ex-dividend NOK 2.25 today
Trifork Group AG12.5.2025 07:30:26 CEST | Press release
27/2025・Trifork Group: Weekly report on share buyback
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom